Jiangsu, China

Shenglin Chen

USPTO Granted Patents = 3 

Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022-2025

where 'Filed Patents' based on already Granted Patents

3 patents (USPTO):

Title: The Innovations of Shenglin Chen: Pioneering Androgen Receptor Antagonists

Introduction

Shenglin Chen, a distinguished inventor based in Jiangsu, China, has made significant contributions to the field of medicine, specifically in the development of innovative compounds for treating diseases. With two patents to his name, Chen is recognized for his dedication to advancing healthcare through his inventive efforts.

Latest Patents

Shenglin Chen's latest inventions include two patents focused on diarylthiohydantoin compounds functioning as androgen receptor antagonists. These applications detail a method for preparing these compounds, including their pharmaceutical compositions. The diarylthiohydantoin compound shows a potent antagonistic effect on androgen receptors and demonstrates excellent antitumor properties. This innovative approach offers potential treatment options for cell proliferative diseases mediated by androgen, showcasing Chen's commitment to improving therapeutic strategies in medicine.

Career Highlights

Currently, Shenglin Chen is associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., where his work continues to impact the pharmaceutical industry significantly. His expertise in medicinal chemistry and drug development has positioned him as a vital contributor within his organization.

Collaborations

Throughout his career, Chen has collaborated with esteemed colleagues such as Chunli Shen and Chengde Wu. These partnerships have fostered a creative and innovative environment, enhancing the development of groundbreaking therapeutics and contributing to the advancement of medical science.

Conclusion

Shenglin Chen's pioneering work in the field of androgen receptor antagonists demonstrates the potential of innovative compounds in battling serious diseases. As he continues his research at Chia Tai Tianqing Pharmaceutical Group Co., Ltd., the medical community and patients alike stand to benefit from his groundbreaking inventions. His relentless pursuit of advancement in medicine highlights the vital role inventors play in shaping the future of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…